Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. KMB
stocks logo

KMB

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
4.12B
-16.47%
1.815
+21.01%
4.18B
-13.56%
2.042
+5.79%
4.27B
+2.48%
2.066
+26.74%
Estimates Revision
The market is revising Downward the revenue expectations for Kimberly-Clark Corporation (KMB) for FY2025, with the revenue forecasts being adjusted by -0.36% over the past three months. During the same period, the stock price has changed by -19.21%.
Revenue Estimates for FY2025
Revise Downward
down Image
-0.36%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-0.33%
In Past 3 Month
Stock Price
Go Down
down Image
-19.21%
In Past 3 Month
Wall Street analysts forecast KMB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for KMB is 121.80 USD with a low forecast of 30.00 USD and a high forecast of 162.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
16 Analyst Rating
Wall Street analysts forecast KMB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for KMB is 121.80 USD with a low forecast of 30.00 USD and a high forecast of 162.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
5 Buy
10 Hold
1 Sell
Hold
Current: 104.940
sliders
Low
30.00
Averages
121.80
High
162.00
Current: 104.940
sliders
Low
30.00
Averages
121.80
High
162.00
Argus
Hold
to
Buy
upgrade
$120
2025-11-13
Reason
Argus
Price Target
$120
2025-11-13
upgrade
Hold
to
Buy
Reason
Argus upgraded Kimberly-Clark to Buy from Hold with a $120 price target.
BofA
Anna Lizzul
NULL -> No Rating
downgrade
2025-11-04
Reason
BofA
Anna Lizzul
Price Target
2025-11-04
downgrade
NULL -> No Rating
Reason
BofA analyst Anna Lizzul is moving to No Rating on Kenvue (KVUE) following the announced acquisition of the company by Kimberly-Clark (KMB). The firm believes the stock is no longer trading on fundamentals.
TD Cowen
Hold
downgrade
$130 -> $112
2025-11-04
Reason
TD Cowen
Price Target
$130 -> $112
2025-11-04
downgrade
Hold
Reason
TD Cowen lowered the firm's price target on Kimberly-Clark (KMB) to $112 from $130 and keeps a Hold rating on the shares. The firm updated its model following their acquisition announcement of Kenvue (KVUE).
Evercore ISI
Outperform
to
In Line
downgrade
$150 -> $120
2025-11-04
Reason
Evercore ISI
Price Target
$150 -> $120
2025-11-04
downgrade
Outperform
to
In Line
Reason
Evercore ISI downgraded Kimberly-Clark (KMB) to In Line from Outperform with a price target of $120, down from $150. The firm views the company's acquisition of Kenvue (KVUE) as "opportunistic and gutsy." However, the deal takes Kimberly-Clark from a "low-risk restructuring and reorganization" story to one "with many moving pieces," the analyst tells investors in a research note. Evercore says its math for the combined company's earnings power in 2027 and 2028 does not suggest enough upside relative to standalone Kimberly's consensus estimates to provide an attractive risk/reward trade-off.
Barclays
Equal Weight
maintain
$131 -> $132
2025-11-03
Reason
Barclays
Price Target
$131 -> $132
2025-11-03
maintain
Equal Weight
Reason
Barclays raised the firm's price target on Kimberly-Clark to $132 from $131 and keeps an Equal Weight rating on the shares following the Q3 report. Despite concerns during the quarter as to competitive dynamics in the U.S. diaper category, the company's organic sales "held in," the analyst tells investors in a research note.
JPMorgan
Andrea Teixeira
Neutral
maintain
$127 -> $129
2025-10-31
Reason
JPMorgan
Andrea Teixeira
Price Target
$127 -> $129
2025-10-31
maintain
Neutral
Reason
JPMorgan analyst Andrea Teixeira raised the firm's price target on Kimberly-Clark to $129 from $127 and keeps a Neutral rating on the shares.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Kimberly-Clark Corp (KMB.N) is 13.71, compared to its 5-year average forward P/E of 19.56. For a more detailed relative valuation and DCF analysis to assess Kimberly-Clark Corp 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Strongly Undervalued
5Y Average PE
19.56
Current PE
13.71
Overvalued PE
21.82
Undervalued PE
17.30

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
13.57
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
14.66
Undervalued EV/EBITDA
12.47

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
2.24
Current PS
0.00
Overvalued PS
2.38
Undervalued PS
2.09
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders areSelling! The selling amount has increased 1990.18% over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders areSelling! The selling amount has increased 1990.18% over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

KMB News & Events

Events Timeline

(ET)
2025-11-03
14:40:47
Jefferies suggests that Kenvue could attract more interest if visibility enhances.
select
2025-11-03
10:40:38
Kenvue Activist D.E. Shaw Rescued by Kimberly-Clark Acquisition, According to WSJ
select
link
2025-11-03
10:00:08
Kimberly-Clark Experiences a 12.0% Decline
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
8.5
00:22 AMGlobenewswire
Repare Therapeutics to Receive $1.82 per Share in Sale to XenoTherapeutics
  • Shareholder Returns: Repare Therapeutics Inc. is set to receive $1.82 per share in cash from its sale to XenoTherapeutics, which is expected to provide substantial cash returns to shareholders, thereby enhancing shareholder confidence.
  • Merger Transaction: The deal will also grant Repare shareholders a non-transferable contingent value right that entitles them to additional cash payments under certain conditions, further increasing potential shareholder gains.
  • Market Reaction: As the transaction progresses, the market has shown a positive response to Repare's stock performance, indicating investor approval of the deal, which may influence future investment decisions.
  • Legal Support: Monteverde & Associates PC, acting as the representing law firm, has recovered millions for shareholders, demonstrating its strong capabilities and reputation in securities class action litigation.
[object Object]
Preview
8.5
12-04SeekingAlpha
Kimberly-Clark provides an update on its partnership with Suzano.

  • Joint Venture Formation: Kimberly-Clark and Suzano S.A. are forming a global joint venture combining Kimberly-Clark's International Family Care and Professional business with Suzano’s tissue assets, valued at approximately $3.4 billion.

  • Ownership Structure: Suzano will acquire a 51% stake for $1.7 billion in cash, while Kimberly-Clark retains 49% equity, with the joint venture managing non-U.S. operations and over 40 brands.

  • Focus Shift: Kimberly-Clark will concentrate on its U.S. consumer tissue and professional businesses, as well as higher-growth personal care categories, which are expected to account for two-thirds of its net sales post-transaction.

  • Governance and Timeline: The new entity will have a five-member board, with Suzano appointing three directors. The deal is expected to close by mid-2026, pending regulatory approvals and internal reorganizations.

[object Object]
Preview
6.0
12-02Benzinga
BNP Paribas Exane Keeps Neutral Rating on Kimberly-Clark, Reduces Price Target to $110

  • Real-time Intelligence: Benzinga Pro offers the fastest news alerts for traders to stay updated on market movements.

  • Exclusive Content: The platform provides exclusive stories and insights generated by Benzinga reporters for its users.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Kimberly-Clark Corp (KMB) stock price today?

The current price of KMB is 104.94 USD — it has decreased -1.12 % in the last trading day.

arrow icon

What is Kimberly-Clark Corp (KMB)'s business?

Kimberly-Clark Corporation is a global company focused on delivering products and solutions that provide better care. The Company's segments include North America and International Personal Care. The North America segment consists of products encompassing each of its five global daily-need categories across consumer and professional channels including disposable diapers, training and youth pants, swim pants, baby wipes, feminine and incontinence care products, reusable underwear, facial and bathroom tissue, paper towels, napkins, wipers, tissue, towels, soaps and sanitizers and other related products. International Personal Care segment consists of three core categories: Baby & Child Care, Adult Care and Feminine Care, including disposable diapers, training and youth pants, swim pants, baby wipes, feminine and incontinence care products, reusable underwear and other related products. Its portfolio of brands includes Huggies, Kleenex, Scott, Kotex, Cottonelle, Depend, and Pull-Ups.

arrow icon

What is the price predicton of KMB Stock?

Wall Street analysts forecast KMB stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for KMB is 121.80 USD with a low forecast of 30.00 USD and a high forecast of 162.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Kimberly-Clark Corp (KMB)'s revenue for the last quarter?

Kimberly-Clark Corp revenue for the last quarter amounts to 4.15B USD, increased 0.14 % YoY.

arrow icon

What is Kimberly-Clark Corp (KMB)'s earnings per share (EPS) for the last quarter?

Kimberly-Clark Corp. EPS for the last quarter amounts to 1.34 USD, decreased -50.19 % YoY.

arrow icon

What changes have occurred in the market's expectations for Kimberly-Clark Corp (KMB)'s fundamentals?

The market is revising Downward the revenue expectations for Kimberly-Clark Corporation (KMB) for FY2025, with the revenue forecasts being adjusted by -0.36% over the past three months. During the same period, the stock price has changed by -19.21%.
arrow icon

How many employees does Kimberly-Clark Corp (KMB). have?

Kimberly-Clark Corp (KMB) has 38000 emplpoyees as of December 05 2025.

arrow icon

What is Kimberly-Clark Corp (KMB) market cap?

Today KMB has the market capitalization of 34.83B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free